Table 2.
Hippocampal protein expression of NMDA receptor subunits (NR1, NR2A and NR2B) in control female (F; n = 12), Beta F (n = 10) control male (M; n = 13) and Beta M (n = 9)
| Treatment | Sex | NR1 | NR2A | NR2B |
|---|---|---|---|---|
| Control | F | 0.62 ± 0.03 | 0.56 ± 0.02 | 0.69 ± 0.03 |
| Control | M | 0.65 ± 0.03 | 0.60 ± 0.02 | 0.73 ± 0.04 |
| Beta | F | 0.58 ± 0.03 | 0.55 ± 0.02 | 0.67 ± 0.02 |
| Beta | M | 0.56 ± 0.02* | 0.51 ± 0.01* | 0.60 ± 0.02*† |
Data are expressed as relative optical density (ROD) of protein of interest/α-tubulin ratio, means ± s.e.m.
Significant effect (P < 0.05) of prenatal treatment within sex.
Significant (P < 0.05) sex difference within prenatal treatment group.